BLCO Bausch & Lomb Corp
Healthcare · Ophthalmic Goods · Market cap: $7.5B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $674.7M |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $505.0K | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $268.1K | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $1.2M | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $1.2M |
| 2026-Q4 | $0 | $2.3M |
Bought$2.0M12 buy days
Sold$678.2M6 sell days
Net insider flow-$676.2Mnet selling · 5 years
Latest trade2026-10-29Munsch Frederick
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-10-29 | Sell | Munsch Frederick | Other C-suite | 112,015 | $20.48 | $2.3M | 1 |
| 2026-08-10 | Sell | Munsch Frederick | Other C-suite | 52,900 | $16.78 | $887.7K | 1 |
| 2026-08-07 | Sell | VON ESCHENBACH ANDREW C. | Director | 6,059 | $16.58 | $100.5K | 1 |
| 2026-08-06 | Sell | VON ESCHENBACH ANDREW C. | Director | 12,500 | $16.50 | $206.2K | 1 |
| 2026-03-06 | Buy | SAUNDERS BRENT L | CEO | 14,700 | $17.14 | $252.0K | 1 |
| 2026-03-06 | Buy | Bailey A Robert D | Other C-suite | 14,600 | $17.15 | $250.4K | 1 |
| 2026-03-06 | Buy | Eldessouky Sam | CFO | 4,000 | $17.13 | $68.5K | 1 |
| 2026-03-03 | Buy | Ross Thomas W. Sr. | Director | 4,500 | $17.68 | $79.6K | 1 |
| 2026-03-02 | Buy | Alfonso Eduardo | Director | 4,300 | $17.90 | $77.0K | 1 |
| 2026-02-27 | Buy | VON ESCHENBACH ANDREW C. | Director | 4,364 | $18.31 | $79.9K | 1 |
| 2026-02-23 | Buy | COLLIS STEVEN H | Director | 15,000 | $17.81 | $267.2K | 1 |
| 2026-02-20 | Buy | ROBERTSON RUSSEL C | Director | 4,400 | $17.90 | $78.8K | 1 |
| 2026-02-19 | Buy | Ling Karen | Director | 4,000 | $17.74 | $71.0K | 1 |
| 2025-05-22 | Buy | SAUNDERS BRENT L | CEO | 22,000 | $11.28 | $248.2K | 1 |
| 2025-05-02 | Buy | VON ESCHENBACH ANDREW C. | Director | 1,695 | $11.76 | $19.9K | 1 |
| 2024-08-05 | Buy | SAUNDERS BRENT L | CEO | 32,250 | $15.66 | $505.0K | 1 |
| 2022-06-01 | Sell | Bausch Health Companies Inc. | 10% owner | 4,550,357 | $17.06 | $77.6M | 1 |
| 2022-05-10 | Sell | Bausch Health Companies Inc. | 10% owner | 35,000,000 | $17.06 | $597.1M | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Bausch Health Companies Inc. | 10% owner | $0 | $674.7M | 2022-06-01 |
| Munsch Frederick | Other C-suite | $0 | $3.2M | 2026-10-29 |
| SAUNDERS BRENT L | CEO | $1.0M | $0 | 2026-03-06 |
| VON ESCHENBACH ANDREW C. | Director | $99.8K | $306.7K | 2026-08-07 |
| COLLIS STEVEN H | Director | $267.2K | $0 | 2026-02-23 |
| Bailey A Robert D | Other C-suite | $250.4K | $0 | 2026-03-06 |
| Ross Thomas W. Sr. | Director | $79.6K | $0 | 2026-03-03 |
| ROBERTSON RUSSEL C | Director | $78.8K | $0 | 2026-02-20 |
| Alfonso Eduardo | Director | $77.0K | $0 | 2026-03-02 |
| Ling Karen | Director | $71.0K | $0 | 2026-02-19 |
| Eldessouky Sam | CFO | $68.5K | $0 | 2026-03-06 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2026-02-19 → 2026-03-06 | 9 | $1.2M | 69 | -9.5% (-15.8% raw) | -25.7% (-16.7% raw) | -20.2% (-8.6% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.